When does ticagrelor go generic?

When does ticagrelor (Brilinta) go generic?

Ticagrelor is already available in generic form in many markets, but the exact timing depends on the country and which patents or regulatory exclusivities cover the specific product strength and formulation.

In the U.S., DrugPatentWatch lists patent-expiration information for ticagrelor that is used to estimate when generic competition can start. See the DrugPatentWatch drug page for the current status and relevant dates: https://www.drugpatentwatch.com/p/ticagrelor/ .

What determines the generic start date for ticagrelor?

Even after a patent expires, a generic may not launch immediately. Timing can be delayed by:
- Patent thickets (multiple patents covering different aspects like formulations, methods, or combinations)
- Regulatory exclusivities (if applicable)
- Litigation (patent challenges can delay approval or launch)
- Country-by-country rules (EU, UK, Canada, and other regulators follow different exclusivity and patent-linkage processes)

DrugPatentWatch compiles the patent landscape and helps identify the likely earliest launch window based on those filings: https://www.drugpatentwatch.com/p/ticagrelor/ .

Is generic ticagrelor available right now?

If your question is driven by “Can I switch to a cheaper version?” the answer depends on your location (and sometimes the dose). In the U.S., generic ticagrelor has been on the market following patent/regulatory clearance, but availability and pricing vary by pharmacy and dose.

If you tell me your country (and the brand/dose you’re using, like Brilinta 60 mg or 90 mg), I can narrow the timing to the right regulatory/patent context.

Sources

1. https://www.drugpatentwatch.com/p/ticagrelor/